Latest News

PharmOptima Research Scientist Presents New Assay at 2013 International SMA Research Group Meeting

Monday, July 8, 2013

PharmOptima Research Scientist Presents New Assay at 2013 International SMA Research Group Meeting

PharmOptima LLC and Ophthy-DS announce Strategic Alliance

Monday, July 1, 2013

West Michigan preclinical CROs streamline ocular service offerings through alliance

PharmOptima LLC Scientist Presents Study Poster at ARVO 2013

Wednesday, May 15, 2013

PharmOptima LLC announced that five of its scientists authored a study paper presented by Mr. Douglas Decker at ARVO 2013 held in Seattle last week

PharmOptima LLC and Jeffrey L. Edelman, Ph.D. form Joint Research Alliance

Wednesday, January 16, 2013

PharmOptima LLC and Dr. Jeffrey Edelman will be collaborating in advancing various animal models for researchers in the ophthalmic field.

PharmOptima LLC Completes Facility Addition

Tuesday, August 21, 2012

PharmOptima LLC has completed a 5,000 sq.ft. addition to its laboratory facilities providing increased capacity for its growing in vivo and analytical activities

PharmOptima LLC adds additional analytical equipment

Saturday, July 21, 2012

PharmOptima LLC is presently expanding its’ physical facilities at it’s Portage, Michigan laboratories and has already increased analytical capabilities through the addition of state of the art equipment.

PharmOptima Scientists Present Study Posters at the June 2012 Spinal Muscular Atrophy Foundation Seminar

Tuesday, June 26, 2012

Scientists from PharmOptima LLC presented study findings on biomarker assays and optimization of peripheral blood mononuclear cell processing for SMN protein signal analysis in  posters at the 2012 Spinal Muscular Atrophy Foundation Seminar

PharmOptima LLC recognized as a Collaborator for the Spinal Muscular Atrophy Foundation

Monday, June 11, 2012

PharmOptima LLC has been recognized on the web site of the Spinal Muscular Atrophy Foundation as a research collaborator